2

We are the right partner forall kind of transactions in the Pharma / Healthcare Industry

Partnering• Licensing out (worldwide)• Licensing in (worldwide)• Supply & distribution agreements• Business planning

Product Transactions(asset deals)• Divestments of products /

brands / portfolios • Acquisitions of products /

brands / portfolios

Mergers &Acquisitions (share deals)• Divestments and acquisitions of

companies • Specialization in divestment of

production sites• Strategic alliances (joint ventures) Core

Business Areas

StrategicConsulting• Valuation for financial institutions• Portfolio management• Marketing & sales strategies• Change management• Executive Search• Post Merger Integration

3

Why we arethe right partner for you!

5 STEPSTO SUCCESS

1

5

4

2

Expertise25 years in-depth expertise in all aspects of Pharma M&A, Product transactions, Partnering and Strategic consulting

AdvisorsFully involved Senior Advisors with executive management expertise in the pharmaceutical industry

SuccessTarget oriented, efficient, intelligent and successful project managementMore than 500 transactions closed

GlobalUnique global database and comprehensive network of healthcare and M&A experts

ExperienceBroad experience in cross-border-transactions worldwide

1

5

2

4

33

1

5

4

3

2

Our team

Managing PartnerKLAUS MANLIK

PrincipalMICHAEL COMPANIE

Senior DirectorMATHIAS KÄSEBIER

Portfolio Analyst / ConsultantULRIKE DÄXL

Long term expertise in numerous national and international projects.

Specialist in M&A and product transfers.Broad marketing & sales and business development experience in leading positions in big pharma and medium-sized enterprises.

In-depth experience in the pharmaceutical industry.

Specialist in international M&A project management.

Specialization in the divestment and acquisition of products and brands.

Long term experience in operative and strategic business development. Specialist in M&A and product divestiture processes and growth strategies.Previous industry experience especially in OTC/Wellness/Phyto included:CEO of Heel Inc., Albuquerque, USA. Director of Consumer Health Americas, Boehringer Ingelheim, International Marketing Director Natural Health.

Expert knowledge of general and comparative financial analysis. Specialist in establishing growth strategies, e.g. creating shareholder value. Previous industry experience as Senior Portfolio Manager/ Analyst for healthcare stocks (pharma, medtech & biotech) in several asset management companies, including in-depth analysis and stock picking strategies.

5

Dr. Renate Moser – Regional Associate Austria, Wien (Austria)Thomas Merrifield – Territorial Associate North America incl. Canada, South CarolinaDr. Kah Foo – Territorial Associate Asia (incl. SEA,, Japan, Korea), SingaporeVolker Adam – Regional Associate Mexico, Mexico City (Mexico)

Our international team

Lukas Radtke – Regional Associate Brazil and Mercosur, Sao Paulo (Brazil)

Arun Kumbhat – Territorial Associate IndiaPablo Faglioli – Territorial Associate ArgentinaDr. Diether Wienbeck – Territorial Associate CEE, Russia, CIS

Headquarter – Germany, Starnberg

Yornick Hurtado – Territorial Associate Central America and Venezuela, Miami (USA)

6

Rx

Generics

OTC

Pharmaceuticalproduction

Biotech

Hospitals

Nutraceuticals

Dermacosmetics

Diagnostics

Medtech

R&D Licensing Projects

Veterinary

OUR KNOW-HOW

7

Our Services forMergers & Acquisitions, Product Transactions and Partnering

Market Intelligence

Strategic Planning

Project Management

Valuation of Business

Fact Sheet / Info Memo

Identification of Candidates

Due Diligence Guidance

Face-to-face meetings

Negotiations

Post Merger Integration

Post Transaction Implementation

Process Monitoring

8

Strategy analysis Strategy developement Strategy planning Implementation Monitoring

Strategic Consultingwith a broad range of services to meet strategic challenges

Organizational change

Company strategy

Sales strategy

Portfolio management

Valuation of business opportunities

Marketing strategy

ALL OVER THE WORLD22.000 companies and 50.000 individuals

10

Proprietary global databaseBANNERT MANLIK’s unique proprietary global database includes more than 22,000 companies and more

than 50,000 individuals, which guarantees fast-paced and success-oriented project management

43% Europe, incl. Germany & CEE30% Central & South America9% USA5% Asia

8% Russia3% Mena2% ROW

11

Contact data of key persons, e.g. management and BD

Successor regulations

Openness to cooperation, joint ventures, acquisitions, etc.

R&D pipeline

Current status and future strategic directions

Financial details

Company coordinates

Classification of production facilities by pharmaceutical forms, packaging materials, etc.

Business areas: ethical drugs, generics, food supplements, etc.

Market segments: Rx, OTC, OTx, Medtech, etc.

Therapeutic areas, further classified by ATC Code

Company type: Pharma, Biotech, PE Start-up, CMO, CRO etc.

Proprietary global databaseAll information has been collected and developed over the last 25 years

Publ

ic in

form

atio

n

Priv

ate

info

rmat

ion

12

Proprietary global databasePrecise and quick customized targeting to identify and match potential candidates

Final Candidates

Core List Candidates:

Short-list Candidates:

Long-list Candidates:

Universe

Potential candidates after analysis

confirmed indication of interest

Indication of interest after teaser

2-3

5

25-30

60-80

100 %All relevant preliminary candidates

13

A selection of successfully completed projects

14

Our referencesIn more than twenty-five years of business, BANNERT MANLIK has successfully conducted more than

500 national and international transactions, ranging from 1m to 100m USD (sales value)

Our Office

Bannert Manlik Consultants GmbHMaximilianstrasse 4e 82319 Starnberg, Germany

www.bannert-manlik.com

Tel: +49 8151 973 65 0 Fax: +49 8151 973 65 25

About Bannert Manlik Consultants

Since 1991, BANNERT MANLIK is one of the leading international strategic consulting firms for the pharmaceutical and healthcare industries.

We assist our clients throughout the entire M&A process, provide portfolio management strategies, as well as support in the realization of international growth and other strategic goals.